ask="9.50"
ask_size="500"
average_daily_volume="368753"
bid="8.25"
bid_size="100"
book_value="3.69"
change="+0.25"
change_from_200_day_moving_average="-2.22"
change_from_50_day_moving_average="-0.42"
change_from_52_week_high="-6.35"
change_From_52_week_low="4.19"
change_in_percent="+3.12%"
close="8.25"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.51"
eps_estimate_next_year="-1.95"
ex_dividend_date="N/A"
float_shares="16063000"
high="8.65"
high_52_weeks="14.60"
last_trade_date="3/2/2017"
last_trade_price="8.25"
last_trade_size="6289"
last_trade_time="4:00pm"
low="7.80"
low_52_weeks="4.06"
market_capitalization="147.23M"
moving_average_200_day="10.47"
moving_average_50_day="8.67"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="25.50"
open="7.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-21.23%"
percent_change_from_50_day_moving_average="-4.82%"
percent_change_from_52_week_high="-43.49%"
percent_change_from_52_week_low="+103.25%"
previous_close="8.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.17"
price_per_sales="150.66"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="1.96"
stock_exchange="NCM"
symbol="STML"
volume="512252"
weeks_range_52="4.06 - 14.60"
